Literature DB >> 2926326

Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.

A M Yee1, J P Buyon, Y K Yip.   

Abstract

The physicochemical properties of apparently acid-labile IFN-alpha from patients with SLE have been studied. The antigenicity, apparent molecular size, and isoelectric point of SLE IFN-alpha are indistinguishable from those of conventional, previously characterized, acid-stable subspecies of IFN-alpha. However, after partial purification by anion-exchange chromatography, SLE IFN-alpha no longer exhibits acid lability, suggesting that other plasma factor(s) are responsible for the acid lability of SLE IFN-alpha. Addition of SLE plasma, but not normal plasma, to conventional acid-stable IFN-alpha renders the exogenous IFN-alpha acid labile. Preliminary results demonstrate that an acid-dependent IFN-inactivating activity can be partially purified from SLE plasma by anion-exchange chromatography.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926326      PMCID: PMC2189267          DOI: 10.1084/jem.169.3.987

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.

Authors:  J J Hooks; G W Jordan; T Cupps; H M Moutsopoulos; A S Fauci; A L Notkins
Journal:  Arthritis Rheum       Date:  1982-04

2.  Interferon inhibits the suppressor T cell response of delayed-type hypersensitivity.

Authors:  J Knop; R Stremmer; C Neumann; E De Maeyer; E Macher
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

3.  Antibodies to alpha-interferon in a patient with systemic lupus erythematosus.

Authors:  S Panem; I J Check; D Henriksen; J Vilcek
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

4.  Immunochemical analysis of Micrococcus lysodeikticus (luteus) F1-ATPase and its subunits.

Authors:  C Urban; M R Salton
Journal:  Biochim Biophys Acta       Date:  1983-08-31

5.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Partial purification and characterization of human gamma (immune) interferon.

Authors:  Y K Yip; R H Pang; C Urban; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Distinction of two subtypes of human leukocyte interferon (IFN-alpha) on B cell activation. B cell proliferation by two subtypes of IFN-alpha.

Authors:  H Harada; K Shioiri-Nakano; M Mayumi; T Kawai
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

9.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

10.  Association of human immunodeficiency virus infection and autoimmune phenomena.

Authors:  R G Kopelman; S Zolla-Pazner
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

View more
  6 in total

1.  Evidence against an autoimmune aetiology for inflammatory bowel diseases.

Authors:  F Pallone; S Fais; M R Capobianchi
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.

Authors:  J Ferbas; J Navratil; A Logar; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

3.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

4.  Thoughts on COVID-19 and autoimmune diseases.

Authors:  Anca D Askanase; Leila Khalili; Jill P Buyon
Journal:  Lupus Sci Med       Date:  2020-04-03

Review 5.  Human natural interferon-alpha producing cells.

Authors:  P Fitzgerald-Bocarsly
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

Review 6.  Autoimmune connective tissue diseases in the COVID-19 pandemic.

Authors:  Lyubomir Dourmishev; Dimitrina Guleva; Joana Pozharashka; Kossara Drenovska; Lyubka Miteva; Snejina Vassileva
Journal:  Clin Dermatol       Date:  2020-12-15       Impact factor: 3.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.